Unternehmen auf Beobachtungsliste setzen
Krones AG
ISIN: DE0006335003
WKN: 633500
Über
Snapshot Unternehmen
Neu: Benachrichtigung aktivieren
Aktuelle Nachrichten per Alarm empfangem
Neu: KI-Factsheet

Coming soon: Zusammenfassung der Unternehmensnachricht durch KI/p>

Krones AG · ISIN: DE0006335003 · Newswire (Unternehmen)
Land: Deutschland · Primärmarkt: Deutschland · EQS NID: 1824529
29 Januar 2024 07:30AM

Krones intends to expand its portfolio into injection molding with the imminent acquisition of Netstal


EQS-News: Krones AG / Key word(s): Miscellaneous
Krones intends to expand its portfolio into injection molding with the imminent acquisition of Netstal

29.01.2024 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Corporate News Release

29 January 2024

Krones intends to expand its portfolio into injection molding with the imminent acquisition of Netstal

Krones is close to sign an agreement regarding the acquisition of 100% of Netstal Maschinen AG (Netstal) from KraussMaffei. Based in Naefels, Switzerland, Netstal is a leading supplier of injection molding machines to the beverage market (PET preforms and caps) as well as to the medical and thin-wall packaging market. The company is a technological leader in its markets and has already been a strategic partner of Krones in the past.

In the 2023 fiscal year, Netstal generated with a workforce of more than 500 employees revenue of more than EUR 200 million. The profitability of the company is currently below the Krones Group level but is expected to close this gap over the coming years. Netstal will be reported as part of the segment Filling and Packaging Technology. Krones finances the purchase with existing liquid funds, but also may take advantage of partial debt financing.

The acquisition of Netstal is benefitting Krones on various dimensions. Netstal’s PET and Cap businesses complement Krones’ product portfolio for the beverage market. With respect to PET closed-loop solutions Krones then covers all technologies required from injection molding to PET container production through to filling/packaging and recycling. The medical and thin-wall packaging segments of Netstal support the Krones strategy to diversify into the medical/pharma market as well as into food and home-personal-care applications. Netstal will retain its business responsibility within Krones, while benefitting from the international set-up and scale of Krones.

The final signing of the transaction is scheduled for beginning of February 2024. With the acquisition of Netstal, Krones continues to succesfully implement its M&A strategy. After signing the transaction is subject to approval under the relevant antitrust legislation. Krones expects the transaction to be completed within the first half of 2024.

 

Contact:
Olaf Scholz
Head of Investor Relations, Krones AG
Tel.: +49 9401 70 1169
Email: olaf.scholz@krones.com

 

 



29.01.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Krones AG
Böhmerwaldstraße 5
93073 Neutraubling
Germany
Phone: +49 (0)9401 701169
Fax: +49 (0)9401 709 1 1169
E-mail: investor-relations@krones.com
Internet: www.krones.com
ISIN: DE0006335003
WKN: 633500
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1824529

 
End of News EQS News Service

1824529  29.01.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1824529&application_name=news&site_id=boersengefluester_html






Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency · Reliability · Credibility
Information regarding Product Information
Montag, 18.11.2024, Kalenderwoche (KW) 47, 323. Tag des Jahres, 43 Tage verbleibend bis EoY.